Post S-8 Companies

[mgland]

RITE. S8 around 7 million 12/30 and asher for 5.5 million 1/16.
On watch. Clear em out it reverses imho

[Wildbilly]

I miss this board, maybe Hopie returns. :)

[hill1323]

STKO is a new one to check into

[mgland]

FGLD. 1-20 R/S coming soon. May be a good post R/S to track
The increased A/S 1 billion is a red flag though

[eztradin]

CAGR will be another double or more. Reversing trend off a post forward split awhile back. eom

[eztradin]

CAGR did a 10:1 F/S awhile back, and insiders own close to a third of the O/S. Might be a bounce opportunity here. Just like an S-8 bounce.

[ProfitChaser]

WTG Joe. You should definitly have your double now. Up 60% today last I looked

[eztradin]

I am close to having a double here, but I want more. LUXD. eom

[eztradin]

Watching LUXD. Could be a fun one when the S-8 finishes. Low O/S. eom

[TraderUsa]

SAPX POST S-8 TODAY... For your information...

[eztradin]

Love these S-8 bounces. :)

[Pennybuster]

OGNG Filling Gap!

[eztradin]

I don't see I-Hub on this disclaimer, but I know they get paid to send e-mails for compensation, because I get them:

http://investorshub.advfn.com/boards/IRP_Members.aspx?method=a

Hmmm.

[eztradin]

OGNG post S-8 play on watch. Also, a gap to fill on chart. eom

[eztradin]

MSMY on watch.

MSMY is a post forward split play. It did a 4:1 F/S late last year. Trading volume has been substantial over the last few days as the shares entered the market. I believe it has a few days left before this makes a significant move.(based on 20M volume per day)

Also, there are promo shares out there being sold.

I'm accumulating.

This will make a big move past .01 and .02

JMHO

[eztradin]

DKAM 250:1 R/S coming; off S-8 watch. eom

[eztradin]

DKAM 75M S-8 filed. Not in. eom

[eztradin]

TTIN up 275% early going. eom

[eztradin]

TTIN on watch.

Small S-8. Last S-8 bounce in July ran to .0045

[eztradin]

PWSV on watch eom

[eztradin]

DKAM S-8 completed late day today. Was .0034 prior to the small S-8 filing a few days ago.

Should bounce back to .003 or more.

[Senorita Roachita]

I meant to say that I looked at the wrong date for their last S-8 which was in Jan. I was looking at Dec.

The S-8 filed on Friday still stands.

[Senorita Roachita]

Looked at the wrong date. Herp. Nevermind.

[Senorita Roachita]

DKAM S-8 play. Filed 6/03/11

Read all about it:

http://www.sec.gov/Archives/edgar/data/873540/000114420411033928/v224869_s8.htm

[eztradin]

ECMZ 60M in dilution. Do the due. Just getting started. Late on filing today, too. eom

[eztradin]

EIHC 20M S-8 eom

[eztradin]

Hit .0012 from .0005's yesterday. eom

[eztradin]

As of April 13, 2011 there were 342,923,686, COWI. EZ double once this S-8 is over, should be close here soon.

Load up time.

[eztradin]

COWI S-8 on watch. Should be getting close to ending soon. Bounce watch. eom

[mgland]

BLUG. On watch. not ready

[mgland]

Interesting dee44. going to watch that one. RW filed 9/24....
The market conditions are such that an underwritten public offering of Registrant’s common stock will not be consummated. Therefore, the Company will not seek to have the Registration Statement declared effective and hereby requests that it should be withdrawn. The Registrant understands that the filing fee for the Registration Statement will not be returned to it. The Registrant believes that the withdrawal of the Registration Statement is consistent with the public interest and protection of investors, as contemplated by Rule 477(a) under the Securities Act.

[dee44]

GETA down to .35 was $ 3.40 two months ago Cancer Cures

[eztradin]

Quick Glance of Recent 8K's(Material Events):

http://www.microcapmarkets.com/fillings.jsp?sParam=8-K&title=Current_Reports_(8-K)&type=F&market=OTCBB

[eztradin]

Quick Glance of recent company financing:

http://www.microcapmarkets.com/news.jsp?sParam=FINANCING&market=OTCBB

[eztradin]

S-8's August 27- September 3, 2010


September 03, 2010
17:12 Form S-8 Lotus Pharmaceuticals, (LTUS) 3 million shares

17:02 Form S-8 Total Nutraceutical Solu (TNUS) 4 million shares

14:06 Form S-8 Ranger Gold Corp. (RNGC) 5 million shares



August 31, 2010
13:58 Form S-8 POS SINGING MACHINE CO INC (SMDM) 250,000 shares which is in addition
to the 37,585,794 filed on August 12, 2010.



August 30, 2010
6:17 Form S-8 Adamis Pharmaceuticals (ADMP) 2,327,398 shares



August 27, 2010
15:51 Form S-8 SALAMON GROUP INC (SLMU) 10,000,000 million shares

14:33 Form S-8 ROBERTSON GLOBAL HEALTH (ASITD) 1,400,000 shares

[eztradin]

Like their technology, but this is one tough market on small businesses. The worse is yet to come in this market.

JMHO

[aries4747]

Yep, that's why I'm playing it cautiously. Looking to see if there's any improvement in the coming financials next month. Really wish they'd been able to take advantage of the cheap debt buy out offered last year. Only needed a few hundred $K. Hoped their Microsoft buddies could have reached in their pockets. LOL.

[eztradin]

The derivative expense is associated with CoroWare's convertible debentures. The derivative liability increases with the increase in CoroWare's stock price, because the underlying embedded conversion feature is indexed to CoroWare's stock. As the derivative liability increases, the derivative expense increases. The interest expense is primarily associated with the amortization of the discount also associated with our convertible debentures.

Another reason to keep the price low. The S-8 is still not done yet, either.

I think the company will go belly up or need to restructure if their sales don't ramp up soon.

JMHO

[eztradin]

Think it is really close now. Low O/S, and should do well once it gets noticed.

5-10 bagga material with volume.

[aries4747]

COWIE (.015): CoroWare, Inc. Reports 2009 Annual Earnings
Revenues and Gross Profits Rebound in 4th Quarter Despite Setbacks and Losses

NOTE: "As of March 31, 2010 there were 9,245,454 shares of the issuer's $.001 par value common stock issued and outstanding."

REDMOND, Wash., May 12, 2010: Coroware today announced its financial results for the year ended on Dec. 31, 2009 ("the 2009 Period").

For the 2009 Period, CoroWare reported revenues of $1,988,710 compared to revenues of $2,392,681 during the year ended December 31, 2008 (the "2008 Period").

Gross Profits increased to $599,669 during the 2009 Period compared to $485,976 during the 2008 Period.

Although revenues in the 2009 period were lower than 2008 as the global economy experienced setbacks prompting customers to reduced spending, sales recovered in the last 5 months of 2009 as a result of new and renewed customer contracts for lab management, IT consulting and software development, as well as steady sales of mobile robots. Gross profits improved during the 2009 Period as CoroWare improved its consulting resource utilization and increased its use of near-shore consulting resources in Latin America.

Total Operating Expenses were further reduced to $1,116,127 for the 2009 period from $1,831,025 in the 2008 period as the Company continued to streamline corporate overhead expenses in 2009.

Loss from Continuing Operations before Other Income decreased to $516,458 for the 2009 period from $1,345,049 in the 2008 period as the Company increased Gross Profits and reduced Total Operating Expenses.

Net loss for the 2009 Period was $5,199,134 compared to net loss of $1,805,852 for the 2008 period. The loss during the 2009 Period includes $2,023,108 of derivative expense and $2,753,840 of interest expense.

The derivative expense is associated with CoroWare's convertible debentures. The derivative liability increases with the increase in CoroWare's stock price, because the underlying embedded conversion feature is indexed to CoroWare's stock. As the derivative liability increases, the derivative expense increases. The interest expense is primarily associated with the amortization of the discount also associated with our convertible debentures. We used the effective interest method to amortize the associated discounts. As such, the interest expense increases exponentially each year as the carrying value of the debenture increases. The loss during 2008 consisted of $1,773,207 from continuing operations and $32,645 from discontinued operations. The 2008 loss includes derivative income of $959,970 and interest expense of $870,791. The derivative income in 2008 was the result of a decrease in our stock price. To record a reduction in the derivative liability, we recorded derivative income. Interest expense associated with the debt discount amortization was lower in 2008 as would be expected using the effective interest method where the amount amortized increases exponentially each year.

"CoroWare's business recovered in 2009 as customers increased purchases in IT consulting, software development services, and CoroCall HiDef video conferencing subscription services," said Lloyd Spencer, CEO of CoroWare, Inc. "In the coming year, CoroWare is focused on growing its revenues, addressing the derivative liabilities that are a result of legacy convertible debenture obligations, and evaluating potential acquisitions related to CoroWare's telepresence initiative."

The full 10K report and all previous reports can be accessed by going to www.coroware.com/investors.aspx.

About CoroWare

Headquartered in Redmond, Washington, CoroWare is a solutions integrator with expertise in mobile robotics, personal telepresence, IT consulting and software development. For more information on CoroWare's products and services, please visit www.CoroWare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: CoroWare, Inc.

CONTACT: CoroWare
Investor Relations Contact:
Lloyd Spencer
[phone] x703
[e-mail]




(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.

[viking69]

yup just got in I saw that , might have a nice run soon :)

[mgland]

ICPA. S8 not done but making a nice bounce off low the other day

[eztradin]

TIV

Watching for a p-up soon. Gap to fill? $5M direct offering in the works, check news/filings.

[eztradin]

Think this S-8 should be done soon. .0103 is the 10 day break.

[eztradin]

It needs a "Q" on it; it will trade just fine. :)

[aries4747]

Sure do wish they'd find some way to tidy up this debt.

http://www.sec.gov/Archives/edgar/data/1156784/000146340309000048/0001463403-09-000048-index.htm

Other Events

As previously reported in our filings with the Securities and Exchange Commission, on July 21, 2006, CoroWare, Inc. consummated a Securities Purchase Agreement (the “Purchase Agreement”) dated July 21, 2006 with Yorkville Advisors LLC (“Yorkville”) providing for the sale by CoroWare to Yorkville of our 10% secured convertible debentures in the aggregate principal amount of $2,825,000 (the “Debentures”) of which $1,250,000 was advanced immediately, $575,000 was advanced in August 2006 and the last installment of $1,000,000 was advanced on December 7, 2006. The Debentures mature on the third anniversary of the date of issuance. The holder of the Debentures may, at any time, convert amounts outstanding under the Debentures into shares of common stock of CoroWare at a fixed conversion price per share equal to $0.04. Our obligations under the Purchase Agreement are secured by substantially all of the assets of CoroWare and those of our wholly owned subsidiary, CTI.

On March 31, 2009, Yorkville assigned the Debentures to Field Nominees Ltd. Account #1365334. (“Field”) for the beneficial interest of ThreeAM SPC Ltd. (in voluntary liquidation) (and together with Field, “ThreeAM”).

On July 24, 2009, we entered into a Forbearance and Settlement Agreement (the “Forbearance Agreement”) with ThreeAM pursuant to which we were to make a cash payment of $350,000 to ThreeAM prior to September 15, 2009 in full satisfaction of the obligations under the Debentures, and ThreeAM agreed to forego exercising its rights and remedies under the Debentures.

As of October 16, 2009, we had not yet made the cash payment of $350,000 to ThreeAM pursuant to the Forbearance Agreement but had been in discussions with ThreeAM regarding settlement of the debt. On that date, we received notice from the Joint Voluntary Liquidator of ThreeAM indicating that the Debentures had been transferred to YA Global Investments, L.P., which we believe to be an affiliate of Yorkville. Although we have begun discussions with YA Global Investments, we cannot be certain of the outcome of such discussions or whether they will agree to settle our obligations under the Debentures on terms similar to those of our agreement with ThreeAM.

On October 21, 2009, we received a notice from Yorkville Advisors, LLC, as the Investment Manager of YA Global Investments, L.P, indicating its intent to convert $9,800 of the amount due under the Debentures into 143,485 shares of CoroWare common stock.

[KIRBY]

sounds good to me.

[eztradin]

If not, we can add more, or buy back later. The mkt. cap is much less
than a shell:

#
Estimated Market Cap
$130,907 as of Mar 29, 2010

[KIRBY]

Good morning, thanks.

[mgland]

GM. Cowi after S8 share structure should be about 9 million OS.
worth tracking this one.